GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AcouSort AB (OSTO:ACOU) » Definitions » Capex-to-Revenue

AcouSort AB (OSTO:ACOU) Capex-to-Revenue : 0.22 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is AcouSort AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

AcouSort AB's Capital Expenditure for the three months ended in Mar. 2024 was kr-0.30 Mil. Its Revenue for the three months ended in Mar. 2024 was kr1.36 Mil.

Hence, AcouSort AB's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.22.


AcouSort AB Capex-to-Revenue Historical Data

The historical data trend for AcouSort AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AcouSort AB Capex-to-Revenue Chart

AcouSort AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.32 0.44 0.20 0.20

AcouSort AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.16 0.13 - 0.22

Competitive Comparison of AcouSort AB's Capex-to-Revenue

For the Biotechnology subindustry, AcouSort AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AcouSort AB's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AcouSort AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where AcouSort AB's Capex-to-Revenue falls into.



AcouSort AB Capex-to-Revenue Calculation

AcouSort AB's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.13) / 5.534
=0.20

AcouSort AB's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.3) / 1.357
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AcouSort AB  (OSTO:ACOU) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


AcouSort AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of AcouSort AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AcouSort AB (OSTO:ACOU) Business Description

Traded in Other Exchanges
Address
Medicon Village, Lund, SWE, SE-223 81
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company products include AcouTrap, AcouWash, and AcouPlasma.

AcouSort AB (OSTO:ACOU) Headlines

No Headlines